Вы находитесь на странице: 1из 6

7/28/2016 Clinicalmanifestationsandcausesofcentraldiabetesinsipidus

OfficialreprintfromUpToDate
www.uptodate.com2016UpToDate

Clinicalmanifestationsandcausesofcentraldiabetesinsipidus

Author SectionEditor DeputyEditor


DanielGBichet,MD RichardHSterns,MD JohnPForman,MD,MSc

Alltopicsareupdatedasnewevidencebecomesavailableandourpeerreviewprocessiscomplete.
Literaturereviewcurrentthrough:Jun2016.|Thistopiclastupdated:Oct27,2015.
INTRODUCTIONCentraldiabetesinsipidus(CDI)ischaracterizedbydecreasedreleaseofantidiuretichormone(ADH,
alsocalledargininevasopressinorAVP),resultinginavariabledegreeofpolyuria.LackofADHcanbecausedby
disordersthatactatoneormoreofthesitesinvolvedinADHsecretion:thehypothalamicosmoreceptorsthesupraoptic
orparaventricularnucleiorthesuperiorportionofthesupraopticohypophysealtract[1].Bycontrast,damagetothetract
belowthemedianeminenceortotheposteriorpituitarygenerallycausesonlytransientpolyuria,becauseADHproducedin
thehypothalamuscanstillbesecretedintothesystemiccirculationviatheportalcapillariesinthemedianeminence[1].
(See"Hypothalamicpituitaryaxis".)

TheclinicalmanifestationsandcausesofCDIwillbereviewedhere.ThetreatmentofCDI,theclinicalmanifestationsand
causesofnephrogenicdiabetesinsipidus(DI),andthediagnosticapproachtothepolyuricpatientarediscussed
separately.(See"Treatmentofcentraldiabetesinsipidus"and"Clinicalmanifestationsandcausesofnephrogenicdiabetes
insipidus"and"Diagnosisofpolyuriaanddiabetesinsipidus".)

CLINICALMANIFESTATIONSPatientswithuntreatedcentraldiabetesinsipidus(CDI)typicallypresentwithpolyuria,
nocturia,and,duetotheinitialelevationinserumsodiumandosmolality,polydipsia.Theymayalsohaveneurologic
symptomsrelatedtotheunderlyingneurologicdisease.

TheserumsodiumconcentrationinuntreatedCDIisofteninthehighnormalrange,whichisrequiredtoprovidethe
ongoingstimulationofthirsttoreplacetheurinarywaterlosses.Moderatetoseverehypernatremiacandevelopwhenthirst
isimpairedorcannotbeexpressed.Thiscanoccurinpatientswithcentralnervoussystemlesionswhoalsohave
hypodipsiaoradipsia,ininfantsandyoungchildrenwhocannotindependentlyaccessfreewater,andinthepostoperative
periodinpatientswithunrecognizeddiabetesinsipidus(DI).(See"Etiologyandevaluationofhypernatremiainadults",
sectionon'Adipsicdiabetesinsipidus'.)

PatientswithCDImaydevelopdecreasedbonemineraldensityatthelumbarspineandfemoralneck,eveninthose
treatedwithdesmopressin(dDAVP)[2].ItisunclearhowthedeficiencyofADHresultsinboneloss,particularlysince
treatmentfailstopreventbonedisease.However,sinceADHactsuponbothV1andV2receptorsanddesmopressin
principallyuponV2receptors,onepossiblemechanismisthatactivationofV1receptorsstimulatesboneformation.

CAUSESThemostcommoncausesofcentraldiabetesinsipidus(CDI),accountingforthevastmajorityofcases,are
idiopathicdiabetesinsipidus(DI)[1,3,4],primaryorsecondarytumorsorinfiltrativediseases(suchasLangerhanscell
histiocytosis)[5],neurosurgery,andtrauma.Inareportof79childrenandyoungadults,forexample,CDIwasidiopathicin
52percentandresultedfromatumororinfiltrativediseasein38percent[4].Inanothercohortof147childrenfollowed
from2000to2013inasingleNorthAmericancenter,themostcommonsinglediagnosiswascraniopharyngioma(25.2
percent)[6].

Cranialmagneticresonanceimaging(MRI)toidentifyhyperintensitiesintheposteriorpituitaryorthickeningofthepituitary
stalkcanhelpdeterminethecauseofCDI[79].

AnyformofCDIcanbeexacerbatedorfirstbecomeapparentduringpregnancy,sincecatabolismofantidiuretichormone
(ADH,alsocalledargininevasopressinorAVP)isincreasedbyvasopressinasesreleasedfromtheplacenta[10,11].(See
"Renalandurinarytractphysiologyinnormalpregnancy".)

IdiopathicCDIApproximately30to50percentofcasesofCDIareidiopathic,beingassociatedwithdestructionofthe
hormonesecretingcellsinthehypothalamicnuclei.Ithasbeensuggestedthatanautoimmuneprocessisinvolvedin
many,ifnotmost,patients[1215].Insightintothemechanismofautoimmunityinsomeindividualswasprovidedbya
longitudinalstudyevaluatingthepresenceofcytoplasmicantibodiesdirectedagainstvasopressincells(Abpositive)in
patientswithendocrineautoimmunediseasesbutinitiallywithoutCDI[13].Amongalmost900suchpatients,9foundto
beAbpositiveand139Abnegativecontrolswereprospectivelyfollowed.Atfouryears,noneofthecontrolsdeveloped
CDI.Bycomparison,fourofthenineAbpositivepatientshadpartialCDIatstudyentryand,amongtheremainingfive
patients,threedevelopedpartialDIandonedevelopedcompleteCDI.

Thisautoimmuneprocessischaracterizedbylymphocyticinflammationofthepituitarystalkandposteriorpituitarythat
resolvesafterdestructionofthetargetneurons.MRIearlyinthecourseoftenrevealsthickeningorenlargementofthese
structures.

TheincidenceofsuchantibodiesinthosewithCDI,theirassociationwithotherautoimmunediseases,andtheir
correlationwithradiologicfeatureswasevaluatedinastudyof150patientswithCDIthatwasperformedbythesame
Italiangroup[14].Thediseasewasidiopathicin43percent,familialin4percent,granulomatousin8percent,and
secondarytocranialtrauma,tumor,orsurgeryin45percent.Antibodiestovasopressincellswerefoundinaboutonethird
ofthepatientswithidiopathicdiseaseandapproximatelyonequarterofpatientswithnonidiopathicdisease.Antibody
positivitywasindependentlyassociatedwithagelessthan30yearsatdiseaseonsetinthosewithidiopathicdisease,a
historyofautoimmunedisease,orpituitarystalkthickening.AutoimmuneCDIwashighlyprobableinyoungpatientswitha
historyofautoimmunediseaseandpituitarystalkthickening.

https://www.uptodate.com/contents/clinicalmanifestationsandcausesofcentraldiabetesinsipidus?topicKey=NEPH%2F2373&elapsedTimeMs=7&source=s 1/6
7/28/2016 Clinicalmanifestationsandcausesofcentraldiabetesinsipidus

OtherautoimmunemechanismsforCDIincludeimmunoglobulin(Ig)G4relatedsystemicsyndrome,whichmaybe
successfullytreatedwithglucocorticoids[16,17],andgranulomatosiswithpolyangiitis(GPA),asystemicdisease
characterizedbypauciimmune,necrotizing,smallvesselvasculitis,oftenassociatedwithpositiveantineutrophil
cytoplasmicantibodies(ANCA)[18].(See"OverviewofIgG4relateddisease"and"Clinicalmanifestationsanddiagnosis
ofgranulomatosiswithpolyangiitisandmicroscopicpolyangiitis".)

Thickeningofthepituitarystalkisanonspecificfinding,sincesomepatientswiththisfindinglaterdevelopagerminomaor
histiocytosis[19].Inchildren,progressivethickeningofthestalkasdeterminedbyserialMRIsisstronglysuggestiveofa
germinoma[4].

Anteriorpituitaryhormonedeficiency,withdecreasedreleaseofgrowthhormone,thyroidstimulatinghormone,and
adrenocorticotropichormone,alsomaybepresentordevelopinpatientswithidiopathicCDI[4,20].However,some
patientswhodevelopananteriorpituitaryendocrinopathyyearsafterthediagnosisofCDImayhaveapituitaryor
suprasellartumor,suggestingthattheinitialabnormalitywasduetoanoccultpathologicprocess.Asanexample,inone
studyof16patientsfirstdiagnosedwithidiopathicCDI,thedetectionofevolvinggonadotropindeficiencyinthree
individualsresultedinthediagnosisofpituitaryorsuprasellargerminomas20,6,and3yearsaftertheinitialpresentation
[21].Thesedata,ifconfirmed,suggestthatsuchpatientsshouldundergoregularendocrinefollowup.(See"Diagnostic
testingforhypopituitarism".)

FamilialandcongenitaldiseaseAnumberoffamilialandcongenitaldiseaseshavebeenassociatedwithCDI.These
includefamilialCDI,Wolframsyndrome,andcongenitaldiseasessuchascongenitalhypopituitarismandseptooptic
dysplasia.

FamilialCDIFamilialCDI,alsocalledfamilialneurohypophysealDIorFNDI(MIM125700),isusuallyan
autosomaldominantdiseasecausedbymutationsinthegeneencodingantidiuretichormone(ADH,alsocalledarginine
vasopressinorAVP)[22].ADHanditscorrespondingcarrier,neurophysinII,aresynthesizedasacompositeprecursorby
themagnocellularneuronsofthesupraopticandparaventricularnucleiofthehypothalamus[23].

ThemechanismbywhichasinglemutantallelecausesautosomaldominantFNDIinvolvestheinductionofmagnocellular
celldeathbytheaccumulationofmisfoldedAVPprecursorswithintheendoplasmicreticulum[24].Transfectionstudiesin
mouseneuroblastomaNeuro2Acellssuggestthatthemechanism(s)bywhichadominantmutantallelecauses
neurogenicDIisaresultoftheaccumulationofargininevasopressinfibrillaraggregateswithintheendoplasmicreticulum,
asocalledtoxicgainoffunction[25].Thisprocessismechanisticallysimilartothatseeninotherneurodegenerative
diseases,suchasHuntingtonandParkinsondiseases[26]

AlthoughthehandlingofmisfoldedAVPmutantscouldaccountforthedelayedonsetandprogressivenatureofdominant
FNDI,theprecisemechanismofmagnocellulartoxicityisstillunknown[25].Individualswithautosomaldominantdisease
progressivelydevelopAVPdeficiency,andclinicalandhormonalsignsusuallydonotdevelopuntilseveralmonthsor
yearsafterbirth[27].

ThisautosomaldominantformofCDIcontrastswithcongenitalAVPdeficiencythathasbeendescribedinthreefamilies
withautosomalrecessiveCDI.TwofamiliesbearamissensevariationaffectingtheseventhaminoacidoftheAVP
nonapeptide(p.Pro26Leu)[28,29],andfourmembersofonefamilywithtwoloopsofinbreedingbearalargedeletion
involvingthemajorityoftheAVPgeneaswellastheintergenicregionbetweentheAVPandOXTgene[30].Affected
membershaveearlypolyuriaandhypernatremia,incontrasttotheautosomaldominantdiseasementionedabove.The
existenceofthisautosomalrecessive,earlyonsetCDIisimportantbecauseitmustbeconsidered,alongwithcongenital
nephrogenicDI,inthedifferentialdiagnosisofcongenitalpolyuriaanddehydration,andtherapyforthesedisordersdiffer.

WolframsyndromeTheWolframorDIDMOAD(diabetesinsipidus,diabetesmellitus,opticatrophy,anddeafness)
syndromeischaracterizedbyCDI,diabetesmellitus,opticatrophy,anddeafness,withcognitiveandpsychiatricissues
thatmayappearlaterinlife[31]itisinheritedasanautosomalrecessivetraitwithincompletepenetrance.TheWolfram
syndromeiscausedbyatleasttwodifferentgenes:WFS1andZCD2[32].Bothencodeendoplasmicreticulumproteins
andseemtoaffectcalciumhomeostasis.Wolframin,theproductofWFS1,isexpressedinanumberoftissues,including
thepancreas[33]andbrainsupraopticparaventricularnuclei[34].DIinthisdisorderisduetolossofvasopressin
secretingneuronsinthesupraopticnucleusandimpairedprocessingofvasopressinprecursors[35].

VariationsinWFS1alsopredisposetotype2diabetesmellitus[36].WFS1negativelyregulatesakeytranscriptionfactor
involvedinendoplasmicreticulum(ER)stresssignaling,resultinginpancreaticbetacelldeathandpossiblyin
magnocellularcelldeath,whichcouldexplainthevasopressindeficiency[37].(See"Classificationofdiabetesmellitusand
geneticdiabeticsyndromes",sectionon'Wolframsyndrome'.)

CongenitalhypopituitarismCDIhasbeendescribedinpatientswithcongenitalhypopituitarismwithorwithout
ectopiaoftheposteriorpituitarylobe[3840].Thedefectsinposteriorpituitaryfunctioninthesedisordersinclude
symptomaticCDI,nocturia,reducedADHreleaseafterosmoticchallenge,andhypodipsiaorpolydipsia.Thesefindings
maybeassociatedwithisolatedgrowthhormonedeficiencyormultipleanteriorpituitaryhormonedeficiencies.

SeptoopticdysplasiaCDIcanbeseeninanumberofcongenitalcerebralmidlineabnormalities.Asanexample,
septoopticdysplasia(SOD)hasbeenassociatedwithdefectsinbothanteriorandposteriorpituitaryfunction[41,42].
SODisahighlyheterogeneousconditionwithphenotypesthatincludemidlineandforebrainabnormalitiesaswellasoptic
nerveandpituitaryhypoplasia.MostcasesofSODaresporadic,butfamilialcaseshavebeendescribedinassociation
withmutationsingenesfordevelopmentaltranscriptionfactors(suchasHESX1)thatareessentialfornormal
forebrain/pituitarydevelopment[43].AffectedpatientsmayhaveabnormalthirstaswellasadefectinADHrelease
[42,44].Asaresult,werecommendmonitoringoftheserumsodiuminthesepatientsonceperweekforonemonth,and
thenifstable,onceeverysixmonths.

https://www.uptodate.com/contents/clinicalmanifestationsandcausesofcentraldiabetesinsipidus?topicKey=NEPH%2F2373&elapsedTimeMs=7&source=s 2/6
7/28/2016 Clinicalmanifestationsandcausesofcentraldiabetesinsipidus

NeurosurgeryortraumaCDIcanbeinducedbyneurosurgery(usuallytranssphenoidal)ortraumatothehypothalamus
andposteriorpituitary[4549].TheincidenceofCDIinthesepatientsvarieswiththeextentofinjury,rangingfrom10to20
percentaftertranssphenoidalremovalofanadenomalimitedtothesellatoashighas60to80percentafterremovalof
verylargetumors.

AmuchlowerrateofpostoperativeCDIhasbeenreportedwithminimallyinvasiveendoscopicpituitarysurgery(2.7
percentpermanentand13.6percenttransient)[50].Aserumsodiumhigherthan145meq/Lwithinthefirstfivedays
postoperativelyhadahighpredictivevalueforpermanentDIdevelopment.Bycontrast,patientswithaserumsodiumless
than145meq/Linthefirstfivedayspostoperativelywillrarely,ifever,developpermanentDI,therebyvalidatingshort
postoperativeinpatientstayswithminimalriskofreadmissionforDImanagement.

CraniopharyngiomahasbeenassociatedwithCDIbothbeforesurgeryandparticularlyaftersurgery[47,51].Asomewhat
differentresponsehasbeendetectedaftertransfrontalsurgeryforacraniopharyngioma.Inthissetting,thepolyuria
appearstoresultinatleastsomepatientsfromthereleaseofanADHprecursorfromthehypothalamusthatcompetesfor
butdoesnotactivateADHV2receptors[49].ThesepatientsinitiallyhavehighserumimmunoreactiveADH
concentrations,buttheirADHhaslittleornobiologicalactivityandtheyhavediminishedresponsetoexogenoushormone
replacement.Thus,theybehaveasiftheyhavenephrogenicDI(NDI),althoughthepolyuriaistypicallytransient.

Severedamagetothehypothalamusortractbyneurosurgeryortraumaoftenresultsinatypicaltriphasicresponse
[1,47].Thereisaninitialpolyuricphase,beginningwithin24hoursandlasting4to5daysthisphasereflectsinhibitionof
ADHreleaseduetohypothalamicdysfunction[45].Thisisfollowed,ondays6to11,byanantidiureticphaseinwhich
storedhormoneisslowlyreleasedfromthedegeneratingposteriorpituitary.Duringthisstage,excessivewaterintakecan
leadtohyponatremiabecauseofatransientsyndromeofinappropriateADHsecretion[52].PermanentDImaythenensue
aftertheposteriorpituitarystoresaredepleted.

Mostcasesarenotpermanent[53].Asanexample,patientswithlessseverehypothalamicortractinjuryoftenhave
transientCDIthatbegins24to48hoursaftersurgeryandmaythenresolveoverthefirstweek.Furthermore,notall
patientsprogressthroughallthreephases.Somepatientsdeveloptransienthyponatremia,withorwithoutpreceding
polyuria,andthenrecover.(See"Pathophysiologyandetiologyofthesyndromeofinappropriateantidiuretichormone
secretion(SIADH)".)

Astudyof1571patientswithpituitaryadenomasofalltypeswhounderwenttranssphenoidalsurgeryatthesamecenter
providesinsightintotherelativefrequencyofthesedifferentresponses[54].Amongthesepatients,30percenthad
microadenomasand70percentmacroadenomas.Thekeyfindingswere:

31percenthadimmediatepostoperativepolyuria,17percenthadpolyuriaondaythree,and6percentondayseven.
Ofthesepatients,24percentreceivedoneormoredosesofADH.Afterthreemonths,only0.9percentwerestill
receivingADHorhadpolyuria.

3.4percentofpatientshadtransientpolyuriaandthentransienthyponatremia.

1.1percenthadthetriphasicpatternofpolyuria,hyponatremia,andthenpolyuria.

5.2percenthadonlytransienthyponatremia,eitherwithinonetothreedaysorfivetotendaysaftersurgery.

DespitetherelativelyhighfrequencyofCDIinpatientsundergoingneurosurgery,mostcasesofpolyuriainthissettingare
notduetoCDI[45].Morecommoncausesareexcretionofexcessfluidadministeredduringsurgery[55]and/oran
osmoticdiuresisinducedbymannitolorglucocorticoids(whichcausehyperglycemiaandglucosuria)giveninanattemptto
reducecerebraledema.TheseconditionscanbedifferentiatedfromCDIbymeasuringtheurineosmolalityandthe
responsetowaterrestrictionandtheadministrationofADH.(See"Diagnosisofpolyuriaanddiabetesinsipidus".)

CDIafterneurosurgeryrarelyoccursincombinationwithcerebralsaltwasting.Dependinguponthebalanceoftheensuing
waterandsolute(NaCl)diuresis,hyponatremia,normonatremia,orhypernatremiamaybepresent[56].(See
"Pathophysiologyandetiologyofthesyndromeofinappropriateantidiuretichormonesecretion(SIADH)",sectionon
'Cerebralsaltwasting'.)

CancerPrimaryorsecondary(mostoftenduetolungcancer,leukemia,orlymphoma)tumorsinthebraincaninvolve
thehypothalamicpituitaryregionandleadtoCDI[3].Insomepatientswithmetastaticdisease,polyuriaisthepresenting
symptom[3].

HypoxicencephalopathyHypoxicencephalopathyorsevereischemia(aswithcardiopulmonaryarrestorshock)can
leadtodiminishedADHrelease[1,57].Theseverityofthisdefectvaries,rangingfrommildandasymptomatictomarked
polyuria.Asanexample,overtCDIisunusualinpatientswithSheehan'ssyndrome(postpartumhypopituitarism)even
thoughADHsecretionisoftensubnormal[58].TheappearanceofDIinthesepatientsisconsistentwiththeoccasional
pathologicfindingsofscarringandatrophyinthesupraopticnucleiandposteriorpituitarygland[59].(See"Causesof
hypopituitarism".)

InfiltrativedisordersPatientswithLangerhanscellhistiocytosis(alsocalledhistiocytosisXandeosinophilic
granuloma)areatparticularlyhighriskforCDIduetohypothalamicpituitarydisease[5,60].Upto40percentofpatients
becomepolyuricwithinthefirstfouryears,particularlyifthereismultisysteminvolvementandproptosis.(See"Clinical
manifestations,pathologicfeatures,anddiagnosisofLangerhanscellhistiocytosis".)

Asimilarinfiltrativediseasecanoccurwithsarcoidosis,whichcanalsocausepolyuriaduetoNDI(inducedby
hypercalcemia)orprimarypolydipsia[61].AdditionalinfiltrativedisordersthatrarelycauseCDIincludegranulomatosis
withpolyangiitis(formerlyWegener'sgranulomatosis)[62,63]andautoimmunelymphocytichypophysitis[12,6466]the
latterdisordermayspontaneouslyimprove.(See"Causesofhypopituitarism",sectionon'Hypophysitis'.)

https://www.uptodate.com/contents/clinicalmanifestationsandcausesofcentraldiabetesinsipidus?topicKey=NEPH%2F2373&elapsedTimeMs=7&source=s 3/6
7/28/2016 Clinicalmanifestationsandcausesofcentraldiabetesinsipidus

PostsupraventriculartachycardiaTransientpolyuriaisoccasionallyseenaftercorrectionofasupraventricular
tachycardia[67,68].Bothawaterdiuresisandanatriuresismaybeseen,duerespectivelyduetodecreasedsecretionof
ADHandtoincreasedreleaseofatrialnatriureticpeptide.Thesehumoralchangesmaybemediatedbyincreasesinleft
atrialandsystemicpressure,therebyactivatinglocalvolumereceptors.

AnorexianervosaADHreleaseisoftensubnormalorerraticinpatientswithanorexianervosa,presumablyduetothe
cerebraldysfunction[69].Thisdefectisrelativelymildinmostcasesandpolyuria,whenpresent,isoftenduemostlytoa
primaryincreaseinthirst.

INFORMATIONFORPATIENTSUpToDateofferstwotypesofpatienteducationmaterials,"TheBasics"and"Beyond
theBasics."TheBasicspatienteducationpiecesarewritteninplainlanguage,atthe5thto6thgradereadinglevel,and
theyanswerthefourorfivekeyquestionsapatientmighthaveaboutagivencondition.Thesearticlesarebestfor
patientswhowantageneraloverviewandwhoprefershort,easytoreadmaterials.BeyondtheBasicspatienteducation
piecesarelonger,moresophisticated,andmoredetailed.Thesearticlesarewrittenatthe10thto12thgradereadinglevel
andarebestforpatientswhowantindepthinformationandarecomfortablewithsomemedicaljargon.

Herearethepatienteducationarticlesthatarerelevanttothistopic.Weencourageyoutoprintoremailthesetopicsto
yourpatients.(Youcanalsolocatepatienteducationarticlesonavarietyofsubjectsbysearchingon"patientinfo"andthe
keyword(s)ofinterest.)

Basicstopics(see"Patientinformation:Diabetesinsipidus(TheBasics)")

SUMMARYANDRECOMMENDATIONS

Centraldiabetesinsipidus(CDI)ischaracterizedbydecreasedreleaseofantidiuretichormone(ADH),resultingina
variabledegreeofpolyuria.LackofADHcanbecausedbydisordersthatactatoneormoreofthesitesinvolvedin
ADHsecretion:thehypothalamicosmoreceptorsthesupraopticorparaventricularnucleiorthesuperiorportionof
thesupraopticohypophysealtract.(See'Introduction'above.)

PatientswithuntreatedCDItypicallypresentwithpolyuria,nocturia,and,duetotheinitialelevationinserumsodium
andosmolality,polydipsia.Theymayalsohaveneurologicsymptomsrelatedtotheunderlyingneurologicdisease.
(See'Clinicalmanifestations'above.)

ThecausesofCDIincludeidiopathicdisease,familialandcongenitaldisorders,neurosurgeryortrauma,primaryor
secondarycancers,hypoxicencephalopathy,infiltrativedisorders,postsupraventriculartachycardia,andanorexia
nervosa.ThevastmajorityofcasesareduetoidiopathicCDIorresultfromprimaryorsecondarytumors,or
infiltrativediseases(suchasLangerhanscellhistiocytosis).(See'Causes'above.)

UseofUpToDateissubjecttotheSubscriptionandLicenseAgreement.

REFERENCES

1.RoseBD,PostTW.ClinicalPhysiologyofAcidBaseandElectrolyteDisorders,5thed,McGrawHill,NewYork
2001.p.751.
2.PivonelloR,ColaoA,DiSommaC,etal.Impairmentofbonestatusinpatientswithcentraldiabetesinsipidus.J
ClinEndocrinolMetab199883:2275.
3.KimmelDW,O'NeillBP.Systemiccancerpresentingasdiabetesinsipidus.Clinicalandradiographicfeaturesof11
patientswithareviewofmetastaticinduceddiabetesinsipidus.Cancer198352:2355.
4.MaghnieM,CosiG,GenoveseE,etal.Centraldiabetesinsipidusinchildrenandyoungadults.NEnglJMed2000
343:998.
5.GroisN,FahrnerB,ArceciRJ,etal.CentralnervoussystemdiseaseinLangerhanscellhistiocytosis.JPediatr
2010156:873.
6.WernyD,ElfersC,PerezFA,etal.PediatricCentralDiabetesInsipidus:BrainMalformationsAreCommonand
FewPatientsHaveIdiopathicDisease.JClinEndocrinolMetab2015100:3074.
7.RanadiveSA,ErsoyB,FavreH,etal.Identification,characterizationandrescueofanovelvasopressin2receptor
mutationcausingnephrogenicdiabetesinsipidus.ClinEndocrinol(Oxf)200971:388.
8.DiIorgiN,NapoliF,AllegriAE,etal.Diabetesinsipidusdiagnosisandmanagement.HormResPaediatr2012
77:69.
9.TurcuAF,EricksonBJ,LinE,etal.Pituitarystalklesions:theMayoClinicexperience.JClinEndocrinolMetab
201398:1812.
10.BrewsterUC,HayslettJP.Diabetesinsipidusinthethirdtrimesterofpregnancy.ObstetGynecol2005105:1173.
11.LindheimerMD.Polyuriaandpregnancy:itscause,itsdanger.ObstetGynecol2005105:1171.
12.ImuraH,NakaoK,ShimatsuA,etal.Lymphocyticinfundibuloneurohypophysitisasacauseofcentraldiabetes
insipidus.NEnglJMed1993329:683.
13.DeBellisA,ColaoA,DiSalleF,etal.Alongitudinalstudyofvasopressincellantibodies,posteriorpituitary
function,andmagneticresonanceimagingevaluationsinsubclinicalautoimmunecentraldiabetesinsipidus.JClin
EndocrinolMetab199984:3047.
14.PivonelloR,DeBellisA,FaggianoA,etal.Centraldiabetesinsipidusandautoimmunity:relationshipbetweenthe
occurrenceofantibodiestoargininevasopressinsecretingcellsandclinical,immunological,andradiologicalfeatures
inalargecohortofpatientswithcentraldiabetesinsipidusofknownandunknownetiology.JClinEndocrinolMetab
200388:1629.
15.DeBellisA,ColaoA,BizzarroA,etal.Longitudinalstudyofvasopressincellantibodiesandofhypothalamic
pituitaryregiononmagneticresonanceimaginginpatientswithautoimmuneandidiopathiccompletecentraldiabetes

https://www.uptodate.com/contents/clinicalmanifestationsandcausesofcentraldiabetesinsipidus?topicKey=NEPH%2F2373&elapsedTimeMs=7&source=s 4/6
7/28/2016 Clinicalmanifestationsandcausesofcentraldiabetesinsipidus
insipidus.JClinEndocrinolMetab200287:3825.
16.HaranoY,HondaK,AkiyamaY,etal.ACaseofIgG4RelatedHypophysitisPresentedwithHypopituitarismand
DiabetesInsipidus.ClinMedInsightsCaseRep20158:23.
17.CaturegliP,IwamaS.FromJapanwithlove:anothertesserainthehypophysitismosaic.JClinEndocrinolMetab
201398:1865.
18.KapoorE,CartinCebaR,SpecksU,etal.Pituitarydysfunctioningranulomatosiswithpolyangiitis:theMayoClinic
experience.JClinEndocrinolMetab201499:3988.
19.LegerJ,VelasquezA,GarelC,etal.Thickenedpituitarystalkonmagneticresonanceimaginginchildrenwith
centraldiabetesinsipidus.JClinEndocrinolMetab199984:1954.
20.CzernichowP,PomaredeR,BasmaciogullariA,etal.Diabetesinsipidusinchildren.III.Anteriorpituitary
dysfunctioninidiopathictypes.JPediatr1985106:41.
21.CharmandariE,BrookCG.20yearsofexperienceinidiopathiccentraldiabetesinsipidus.Lancet1999353:2212.
22.ChristensenJH,RittigS.Familialneurohypophysealdiabetesinsipidusanupdate.SeminNephrol200626:209.
23.BurbachJP,LuckmanSM,MurphyD,GainerH.Generegulationinthemagnocellularhypothalamo
neurohypophysialsystem.PhysiolRev200181:1197.
24.RussellTA,ItoM,ItoM,etal.Amurinemodelofautosomaldominantneurohypophysealdiabetesinsipidusreveals
progressivelossofvasopressinproducingneurons.JClinInvest2003112:1697.
25.BirkJ,FribergMA,PrescianottoBaschongC,etal.Dominantprovasopressinmutantsthatcausediabetes
insipidusformdisulfidelinkedfibrillaraggregatesintheendoplasmicreticulum.JCellSci2009122:3994.
26.GregersenN,BrossP,VangS,ChristensenJH.Proteinmisfoldingandhumandisease.AnnuRevGenomicsHum
Genet20067:103.
27.McLeodJF,KovcsL,GaskillMB,etal.Familialneurohypophysealdiabetesinsipidusassociatedwithasignal
peptidemutation.JClinEndocrinolMetab199377:599A.
28.WillcuttsMD,FelnerE,WhitePC.Autosomalrecessivefamilialneurohypophysealdiabetesinsipiduswith
continuedsecretionofmutantweaklyactivevasopressin.HumMolGenet19998:1303.
29.AbuLibdehA,LevyKhademiF,AbdulhadiAtwanM,etal.Autosomalrecessivefamilialneurohypophysealdiabetes
insipidus:onsetinearlyinfancy.EurJEndocrinol2010162:221.
30.ChristensenJH,KvistgaardH,KnudsenJ,etal.AnoveldeletionpartlyremovingtheAVPgenecausesautosomal
recessiveinheritanceofearlyonsetneurohypophysealdiabetesinsipidus.ClinGenet201383:44.
31.BischoffAN,ReiersenAM,ButtlaireA,etal.SelectivecognitiveandpsychiatricmanifestationsinWolfram
Syndrome.OrphanetJRareDis201510:66.
32.AmrS,HeiseyC,ZhangM,etal.Ahomozygousmutationinanovelzincfingerprotein,ERIS,isresponsiblefor
Wolframsyndrome2.AmJHumGenet200781:673.
33.IshiharaH,TakedaS,TamuraA,etal.DisruptionoftheWFS1geneinmicecausesprogressivebetacelllossand
impairedstimulussecretioncouplingininsulinsecretion.HumMolGenet200413:1159.
34.TakedaK,InoueH,TanizawaY,etal.WFS1(Wolframsyndrome1)geneproduct:predominantsubcellular
localizationtoendoplasmicreticuluminculturedcellsandneuronalexpressioninratbrain.HumMolGenet2001
10:477.
35.GabrelsBA,SwaabDF,deKleijnDP,etal.Thevasopressinprecursorisnotprocessedinthehypothalamusof
Wolframsyndromepatientswithdiabetesinsipidus:evidencefortheinvolvementofPC2and7B2.JClinEndocrinol
Metab199883:4026.
36.SandhuMS,WeedonMN,FawcettKA,etal.CommonvariantsinWFS1conferriskoftype2diabetes.NatGenet
200739:951.
37.FonsecaSG,IshigakiS,OslowskiCM,etal.Wolframsyndrome1genenegativelyregulatesERstresssignalingin
rodentandhumancells.JClinInvest2010120:744.
38.YagiH,NagashimaK,MiyakeH,etal.Familialcongenitalhypopituitarismwithcentraldiabetesinsipidus.JClin
EndocrinolMetab199478:884.
39.LukezicM,RighiniV,DiNataleB,etal.Vasopressinandthirstinpatientswithposteriorpituitaryectopiaand
hypopituitarism.ClinEndocrinol(Oxf)200053:77.
40.YamanakaC,MomoiT,FujisawaI,etal.Neurohypophysealfunctionofanectopicposteriorlobeinpatientswith
growthhormonedeficiency.ActaEndocrinol(Copenh)1990122:664.
41.HoytWF,KaplanSL,GrumbachMM,GlaserJS.Septoopticdysplasiaandpituitarydwarfism.Lancet19701:893.
42.MaseraN,GrantDB,StanhopeR,PreeceMA.Diabetesinsipiduswithimpairedosmoticregulationinseptooptic
dysplasiaandagenesisofthecorpuscallosum.ArchDisChild199470:51.
43.McCabeMJ,AlatzoglouKS,DattaniMT.Septoopticdysplasiaandothermidlinedefects:theroleoftranscription
factors:HESX1andbeyond.BestPractResClinEndocrinolMetab201125:115.
44.SeccoA,AllegriAE,diIorgiN,etal.Posteriorpituitary(PP)evaluationinpatientswithanteriorpituitarydefect
associatedwithectopicPPandseptoopticdysplasia.EurJEndocrinol2011165:411.
45.SecklJ,DungerD.Postoperativediabetesinsipidus.BMJ1989298:2.
46.NemergutEC,ZuoZ,JaneJAJr,LawsERJr.Predictorsofdiabetesinsipidusaftertranssphenoidalsurgery:a
reviewof881patients.JNeurosurg2005103:448.
47.GhirardelloS,HopperN,AlbaneseA,MaghnieM.Diabetesinsipidusincraniopharyngioma:postoperative
managementofwaterandelectrolytedisorders.JPediatrEndocrinolMetab200619Suppl1:413.
48.HadjizachariaP,BealeEO,InabaK,etal.Acutediabetesinsipidusinsevereheadinjury:aprospectivestudy.JAm
CollSurg2008207:477.
49.SecklJR,DungerDB,BevanJS,etal.Vasopressinantagonistinearlypostoperativediabetesinsipidus.Lancet
1990335:1353.
50.SigounasDG,SharplessJL,ChengDM,etal.Predictorsandincidenceofcentraldiabetesinsipidusafter
endoscopicpituitarysurgery.Neurosurgery200862:71.
51.CrowleyRK,HamnvikOP,O'SullivanEP,etal.Morbidityandmortalityinpatientswithcraniopharyngiomaafter
https://www.uptodate.com/contents/clinicalmanifestationsandcausesofcentraldiabetesinsipidus?topicKey=NEPH%2F2373&elapsedTimeMs=7&source=s 5/6
7/28/2016 Clinicalmanifestationsandcausesofcentraldiabetesinsipidus

surgery.ClinEndocrinol(Oxf)201073:516.
52.HoornEJ,ZietseR.Waterbalancedisordersafterneurosurgery:thetriphasicresponserevisited.NDTPlus2010
3:42.
53.OlsonBR,GumowskiJ,RubinoD,OldfieldEH.Pathophysiologyofhyponatremiaaftertranssphenoidalpituitary
surgery.JNeurosurg199787:499.
54.HensenJ,HenigA,FahlbuschR,etal.Prevalence,predictorsandpatternsofpostoperativepolyuriaand
hyponatraemiaintheimmediatecourseaftertranssphenoidalsurgeryforpituitaryadenomas.ClinEndocrinol(Oxf)
199950:431.
55.BohnD,DavidsMR,FriedmanO,HalperinML.Acuteandfatalhyponatraemiaafterresectionofa
craniopharyngioma:apreventabletragedy.QJM200598:691.
56.LaredoS,YuenK,SonnenbergB,HalperinML.Coexistenceofcentraldiabetesinsipidusandsaltwasting:the
difficultiesindiagnosis,changesinnatremia,andtreatment.JAmSocNephrol19967:2527.
57.WickramasingheLS,ChazanBI,MandalAR,etal.Cranialdiabetesinsipidusafteruppergastrointestinal
hemorrhage.BrMedJ(ClinResEd)1988296:969.
58.BakiriF,BenmiloudM,VallottonMB.Argininevasopressininpostpartumpanhypopituitarism:urinaryexcretionand
kidneyresponsetoosmolarload.JClinEndocrinolMetab198458:511.
59.JialalI,DesaiRK,RajputMC.AnassessmentofposteriorpituitaryfunctioninpatientswithSheehan'ssyndrome.
ClinEndocrinol(Oxf)198727:91.
60.DungerDB,BroadbentV,YeomanE,etal.Thefrequencyandnaturalhistoryofdiabetesinsipidusinchildrenwith
Langerhanscellhistiocytosis.NEnglJMed1989321:1157.
61.StuartCA,NeelonFA,LebovitzHE.Disorderedcontrolofthirstinhypothalamicpituitarysarcoidosis.NEnglJMed
1980303:1078.
62.GarovicVD,ClarkeBL,ChilsonTS,SpecksU.Diabetesinsipidusandanteriorpituitaryinsufficiencyaspresenting
featuresofWegener'sgranulomatosis.AmJKidneyDis200137:E5.
63.CzarneckiEJ,SpicklerEM.MRdemonstrationofWegenergranulomatosisoftheinfundibulum,acauseofdiabetes
insipidus.AJNRAmJNeuroradiol199516:968.
64.ThodouE,AsaSL,KontogeorgosG,etal.Clinicalcaseseminar:lymphocytichypophysitis:clinicopathological
findings.JClinEndocrinolMetab199580:2302.
65.SatoN,SzeG,EndoK.Hypophysitis:endocrinologicanddynamicMRfindings.AJNRAmJNeuroradiol1998
19:439.
66.NishiokaH,ItoH,FukushimaC.Recurrentlymphocytichypophysitis:casereport.Neurosurgery199741:684.
67.CanepaAnsonR,WilliamsM,MarshallJ,etal.Mechanismofpolyuriaandnatriuresisinatrioventricularnodal
tachycardia.BrMedJ(ClinResEd)1984289:866.
68.FujiiT,KojimaS,ImanishiM,etal.Differentmechanismsofpolyuriaandnatriuresisassociatedwithparoxysmal
supraventriculartachycardia.AmJCardiol199168:343.
69.GoldPW,KayeW,RobertsonGL,EbertM.Abnormalitiesinplasmaandcerebrospinalfluidargininevasopressinin
patientswithanorexianervosa.NEnglJMed1983308:1117.

Topic2373Version10.0

ContributorDisclosures
DanielGBichet,MDGrant/Research/ClinicalTrialSupport:OtsukaPharmaceuticals[ADPKD(Tolvaptan)].Speaker's
Bureau:OtsukaPharmaceuticals[ADPKD(Tolvaptan)].Consultant/AdvisoryBoards:OtsukaPharmaceuticals[ADPKD
(Tolvaptan)].RichardHSterns,MDNothingtodisclose.JohnPForman,MD,MScNothingtodisclose.

Contributordisclosuresarereviewedforconflictsofinterestbytheeditorialgroup.Whenfound,theseareaddressedby
vettingthroughamultilevelreviewprocess,andthroughrequirementsforreferencestobeprovidedtosupportthecontent.
AppropriatelyreferencedcontentisrequiredofallauthorsandmustconformtoUpToDatestandardsofevidence.

Conflictofinterestpolicy

https://www.uptodate.com/contents/clinicalmanifestationsandcausesofcentraldiabetesinsipidus?topicKey=NEPH%2F2373&elapsedTimeMs=7&source=s 6/6

Вам также может понравиться